Additionally, inhibiting the upregulation of FOXO6 inhibits hyperglycemia-induced oxidative stress and apoptosis in RPECs, which is mediated by the downregulation of FOXO6 to activate the AKT/nuclear factor erythroid 2-related factor 2 (Nrf2) pathway [146]. Here, AKT1 is linked to Hyperglycemia.